Deciphering the Angiogenic Switch: The Role of miRNAs in Breast Cancer
IUBMB Life · 2026
DOI: 10.1002/iub.70102 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift IUBMB Life, 2026. Verfasst von Heba Ibrahim Abd El-Moaty und 13 weiteren Autor:innen. Beteiligte Einrichtung: Biological Sciences Department, College of Science, King Faisal University, Al-Ahsa, Saudi Arabia. Hauptthemen laut MEDLINE: MicroRNAs, Neovascularization, Pathologic, Breast Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 225 Literaturangaben. Gefördert von: King Faisal University.
Abstract (Originalsprache)
Angiogenesis, which is the formation of new blood vessels from existing vasculature, exhibits a pivotal role in breast cancer progression and promotes metastasis. This complex biological process is influenced by the dynamic balance of pro‐ and anti‐angiogenic factors within the tumor microenvironment, such as vascular endothelial growth factor, fibroblast growth factors, and angiopoietins. Targeted therapeutic strategies have been developed to interfere with angiogenic signaling, aiming to normalize or inhibit the tumor vasculature. In recent years, miRNAs have arisen as crucial post‐transcriptional regulators of gene expression implicated in angiogenic homeostasis. These microRNAs can function as either promoters or suppressors of angiogenesis by targeting mRNAs that encode angiogenic factors or other signaling molecules. Deregulated expressions of these miRNAs in BC are associated with perturbed angiogenesis, tumor progression, and therapeutic resistance. This review presents a thorough overview of the molecular processes controlling angiogenesis in BC and highlights the emerging roles of angioregulatory miRNAs. The article also discusses the therapeutic potential of targeting miRNAs to modulate tumor angiogenesis, providing novel insights for the development of miRNA‐based diagnostics and therapeutics in BC management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biological Sciences Department, College of Science, King Faisal University, Al-Ahsa, Saudi Arabia.
- Department of Biochemistry, Faculty of Pharmacy, Badr University in Cairo (BUC), Cairo, Egypt.
- Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt.
- Department of Pharmacognosy, Faculty of Pharmacy, Badr University in Cairo, Cairo, Egypt.
- Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
- Pharmacology & Environmental Toxicology, Environmental Studies & Research Institute (ESRI), University of Sadat City, Menoufia, Egypt.
ORCID-Profile: Heba Ibrahim Abd El-Moaty, Ahmed S Doghish, Mai A Abd-Elmawla, Manar Mohammed El Tabaa, Ahmed E Elesawy, Sherif S Abdel Mageed, Osama A Mohammed, Rabab S Hamad, Reda M Mansour
Förderung
- King Faisal University
Zitieren
APA
El-Moaty, H. I. A., Doghish, A. S., Aly, S. H., Abd-Elmawla, M. A., El Tabaa, M. M., Rizk, N. I., Elesawy, A. E., Abdel Mageed, S. S., Mohammed, O. A., Elkhawaga, S. Y., Rizk, H. A., Ashraf, A., Hamad, R. S., & Mansour, R. M. (2026). Deciphering the Angiogenic Switch: The Role of miRNAs in Breast Cancer. IUBMB Life. https://doi.org/10.1002/iub.70102
Vancouver
El-Moaty HIA, Doghish AS, Aly SH, Abd-Elmawla MA, El Tabaa MM, Rizk NI, et al. Deciphering the Angiogenic Switch: The Role of miRNAs in Breast Cancer. IUBMB Life. 2026. doi:10.1002/iub.70102
BibTeX
@article{ElMoaty2026,
author = {El-Moaty, Heba Ibrahim Abd and Doghish, Ahmed S and Aly, Shaza H and Abd-Elmawla, Mai A and El Tabaa, Manar Mohammed and Rizk, Nehal I and Elesawy, Ahmed E and Abdel Mageed, Sherif S and Mohammed, Osama A and Elkhawaga, Samy Y and Rizk, Hanan A and Ashraf, Alaa and Hamad, Rabab S and Mansour, Reda M},
title = {Deciphering the Angiogenic Switch: The Role of miRNAs in Breast Cancer},
journal = {IUBMB Life},
year = {2026},
doi = {10.1002/iub.70102}
}
EUVIMED